Cognitive benefits of hormone therapy: cardiovascular factors and healthy-user bias

Maturitas. 2009 Nov 20;64(3):182-7. doi: 10.1016/j.maturitas.2009.09.014. Epub 2009 Oct 29.

Abstract

Objective: The Women's Health Initiative (WHI) study and its ancillary Memory Study (WHIMS) revealed increased rates of cardiovascular risk, cognitive decline and dementia with opposed conjugated equine estrogens (CEE). As a result, previously accepted observational data suggesting cardiovascular and cognitive benefits and reduced risk for dementia with hormone therapy (HT) were largely attributed to 'healthy-user' bias. The present observational, community-based, case-controlled study examined the 'healthy-user' bias theory by comparing cognitive task performance in two groups of postmenopausal women, who were either HT users or non-users.

Design: Participants were 213 non-demented, postmenopausal women residing in the community and in assisted-living facilities who completed a self-report health questionnaire and underwent a 1-h cognitive test battery. To study the independent contribution of variables in the prediction of cognitive performance, we employed a series of hierarchical regression models adding terms in three stages. The first stage included only HT, the second stage added demographics, and the last stage added alcohol, depression and a cardiovascular risk factor (CVRF) composite derived from a confirmatory factor analysis. The CVRF composite consisted of: stroke, diabetes, hypertension, and hypercholesterolemia.

Results: Although independent samples t-tests revealed no statistically significant differences in the CVRF composite and its individual components between the two groups, HT users tended to possess fewer CVRF than non-users. Conversely, HT users were younger and more educated than non-users. HT users outperformed non-users on 7/9 cognitive variables. The full regression model controlling for CVRF, demographic variables, and mood showed HT users outperformed non-users on measures of verbal memory and abstract reasoning.

Conclusions: While there is some evidence HT users possess fewer preexisting CVRF than non-users, the observed positive association between HT and cognition is not completely explained by this trend.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Bias
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / etiology*
  • Case-Control Studies
  • Cognition / drug effects*
  • Dementia / prevention & control*
  • Educational Status
  • Estrogen Replacement Therapy* / adverse effects
  • Estrogen Replacement Therapy* / psychology
  • Estrogens, Conjugated (USP) / adverse effects
  • Estrogens, Conjugated (USP) / pharmacology
  • Estrogens, Conjugated (USP) / therapeutic use*
  • Female
  • Health Surveys
  • Humans
  • Hypercholesterolemia / etiology
  • Logistic Models
  • Postmenopause
  • Prevalence
  • Reference Values
  • Risk Factors
  • Surveys and Questionnaires

Substances

  • Estrogens, Conjugated (USP)